Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Looks like someone found the password to get into the website last night, although they forgot the news section to update.
I bet Anne has the password but she works part-time. Even though she changed that bit on Linkdin...
Looks like the last 4 or so RNS have not been updated to the news section either
He might be busy working for his new client
Slightly odd that the company hasn't updated the shareholder numbers yet, they previously did it within minutes of the RNS coming out. Maybe Karl has run off with the Wordpress password.
Well you've got a better entry than a lot of us here! So that's a good start.
There's a reason for so much scepticism here from long term holders, it's been pretty disappointing so far but we all know the potential here, patience will be rewarded, eventually
There’s been plenty of time to sell placing shares at a profit since issue. I would like to think that those in for a quick 20% turnaround would have already sold and the rest would be looking at a longer term investment. For the time being any buys are quickly being mopped up by sells but i think I'm more optimistic - thats because I’m new here so plenty of time for the apathy to get me but I'm coming at you with glass half full for the time being!
You need to factor in the placing stock being sold too and whatever DT has left, if he has any at all now we wouldn't know
Looks like it could turn soon. Since the last TR1 capture (7 May) around 3% (17m shares) has gone through in largish sales so Alan could be fully out by now, or very close to it.
Us long term holders have a right to moan, just look at the sp, previous bod failed to deliver and it looks like a slow start from Anne
Hallelujah brother. You gotta have the faith. So many sinners on this board not praising the lord(bod) for all the miracles we've seen these past two years.
No you won’t bridgedogg as there is a lot of moaners but you gotta have the faith.
I think I will like this board
Soup.
You could say that is a careless whisper !!
oh and the founder of Oxilio lives next door to what was George Michaels house, so there's a bit of gossip for you all as well.
Good post Soup, didn't know about Oxillo founders have had good success previously.
Those who are frustrated by the SP, I mentioned at the start of the year that there will be cycles of selling until the hands get stickier up until major news later on in the year. Which is why I want smaller snippets of news now for the traders and the directors to sell into such as NXP001. Once those have gone the volatlity will reduce but your investment decision should be based on if you think there will be success later on to hold.
I'm holding for the what ifs, so the current selling range of now is something I accept. I also accept that we might not get a massive spike from Oxillo payment as those who make 40-50% in the 3p's will bail and we might get even get a drop thereafter.
If you are holding you have to look beyond the noise around you and play the waiting game.
Thanks SD, really appreciate your response. Good news on Oxilio and I'm sure sells will move through shortly.
Looking forward to some positive news on licence and patents.
In response
1) The TR1's are typically covering sells by ex-directors, Dave Tapolczay and Alan Chorlton. Dave T left acrimoniously after a deal he championed turned sour. Chorlton was a long time allie of his.
As to why they are selling out you'll have to ask them.
The TR1 for Joanne Holland (current CSO) is just a change due to placing and not a buy or sell.
CPI have reduced in accordance with their own guidelines as a government vehicle for investment in early start ups.
2) Allenby Research note has its 9p target, I view the note as very good, other have their own opinion.
3) The $360-$450m is for NXP002 and not NXP001 as you suggest.
4) Oxilio, small new company but with strong management pedigree given their founders previous success after starting up Premier Research Plc and growing it to over 1400 staff.
I've got a few questions and hope someone can help me out.
-All of the TR1s are for different people (I assumed they where for the same person)- all the key shareholders are selling out - why?
- What value to you place on the Allenby Capital research note?
- WHat do you make of following on 001 from the research note: NFX is looking to license the asset before Phase I, in which case we would anticipate a global deal value of between $360-450m, in upfront and milestone payments, plus single digit royalties on sales, increasing in value in proportion to the stage of development of the underlying asset....
-What's the view on Oxilio? Looks like a new small company with a bit of cash and no assets. It doesn't seem to make sense to licence to such a company 0 what value can they add over and above what we could do in house?
Thanks
GLA
I hope so too BD1
Thanks FFS didn’t realise that. Seems like the new board are more commercially minded and tight on costs, at least that’s what they say.
If they don’t have upfront monies perhaps the cap on royalties would be lifted? Would hope so.
"Possibly, but as the payment has moved to 'undisclosed' this owuld imply that Oxilio doesnt want the value made public".
There is also the possibility that our own board wouldn't want to make it public either...in the event that it is not that significant.
A lot of trust was lost by the old board which the new board needs to address. Hiding sums of money which might otherwise add some much needed value to our shareprice is not going to achieve that.
Bridgedogg, Oxilio have about £500-600k cash in the bank at present after their recent fund raising, so doubt up front will be significant.
Possibly, but as the payment has moved to 'undisclosed' this owuld imply that Oxilio doesnt want the value made public so it would be a bit cheeky to then state it is 'significant' in the annoucement. Clearly Oxilio want the agreement, I dont see why they would value it less now that they did 6 months ago.
Can anyone explain why it is undisclosed? Surely it will be in the accounts anyway?
If you check the later RNS for the placing you will not that the upfront payment is no longer referred to as "significant". It is now referred to as "undisclosed".
I'm pretty sure that's an adjustment of expectations